Investors & Media
Our Mission
Avalyn Pharma is a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases including pulmonary fibrosis. In partnership with patients, caregivers and physicians, we are developing innovative inhaled therapies that deliver established antifibrotic medicines directly to the lungs, to improve efficacy, enhance tolerability, and establish a new standard of care for patients.